Related Experiment Video
Updated: Jul 14, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Pre-eclampsia: clinical manifestations and molecular mechanisms
Suzanne Baumwell1, S Ananth Karumanchi
1Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Nephron. Clinical Practice
|June 16, 2007
Summary
Preeclampsia, a pregnancy complication affecting 3-5% of pregnancies, involves endothelial dysfunction and elevated anti-angiogenic factors like sFlt1. Understanding these molecular mechanisms is key to developing targeted treatments beyond supportive care.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Renal Pathology
Background:
- Preeclampsia affects 3-5% of pregnancies, posing risks to mother and fetus.
- Risk factors include maternal comorbidities, paternal, and genetic factors.
- Diagnosis involves new hypertension and proteinuria in late pregnancy, with heterogeneous clinical presentations.
Purpose of the Study:
- To explore the molecular mechanisms underlying preeclampsia pathogenesis.
- To investigate the role of endothelial dysfunction and angiogenic factors in preeclampsia.
- To identify potential targets for more directed therapeutic interventions.
Main Methods:
- Review of pathological findings, including glomerular endotheliosis and placental vasculature.
- Analysis of molecular mediators, focusing on angiogenic and anti-angiogenic factors.
- Examination of animal models demonstrating preeclampsia-like conditions.
Main Results:
- Preeclampsia is characterized by placental ischemia and endothelial dysfunction.
- Elevated levels of soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin are implicated.
- sFlt1 overexpression induces glomerular endotheliosis, mimicking renal lesions of preeclampsia.
Conclusions:
- Endothelial dysfunction, driven by an imbalance in angiogenic factors like sFlt1, is central to preeclampsia.
- Understanding these mechanisms could lead to targeted treatments beyond current supportive care and delivery.
- Women with preeclampsia have increased long-term risks for hypertension and cardiovascular disease.
Related Concept Videos
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...